Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages.
about
Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activationSingle copy shRNA configuration for ubiquitous gene knockdown in miceQuantum dots to monitor RNAi delivery and improve gene silencingMicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAsCell- and region-specific miR30-based gene knock-down with temporal control in the rat brainPeptide ligands for pro-survival protein Bfl-1 from computationally guided library screening.Dual function of polycomb group proteins in differentiated murine T helper (CD4+) cellsReversible gene knockdown in mice using a tight, inducible shRNA expression system.Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference.The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in miceRNA silencing in fungi: mechanisms and applications.Specific Jak3 Downregulation in Lymphocytes Impairs γc Cytokine Signal Transduction and Alleviates Antigen-driven Inflammation In VivoRegulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor.T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire.In vivo RNAi screens: concepts and applications.Immunological research using RNA interference technology.Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and BidConditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival.GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells.BCL2A1: the underdog in the BCL2 family.Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection.Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?In vitro silencing of myostatin gene by shRNAs in chicken embryonic myoblast cells.Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.Dying to protect: cell death and the control of T-cell homeostasis.Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells.Double-stranded Let-7 mimics, potential candidates for cancer gene therapy.Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells.Stable silencing of the glucocorticoid receptor in myelin-specific T effector cells by retroviral delivery of shRNA: insight into neuroinflammatory disease.siRNA stabilization prolongs gene knockdown in primary T lymphocytes.RNAi-mediated knockdown of IKK1 in transgenic mice using a transgenic construct containing the human H1 promoter.PTEN suppression promotes neurite development exclusively in differentiating PC12 cells via PI3-kinase and MAP kinase signaling.Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection.
P2860
Q24316356-0F923F6C-120B-43E0-A0A3-D0D19746CD42Q24797255-47A3AA14-6081-4C3A-A235-0A249A3FBA81Q24811402-B464CB0E-671F-416B-893B-595624629DBAQ27863380-71546CD4-CF34-43F6-A76E-06EF0B705FA9Q28115922-DBAE3E89-9109-4304-84CD-FB3DB8800D34Q33763933-610AFC34-2457-4438-A085-25A8FB41A205Q34567408-CFEE6E86-9882-498C-8211-69881ECD182CQ35081245-0C8274AC-3C24-4C4C-AF59-B79E796FAFF2Q35804666-0A39A14D-5BF9-4A60-A84D-E0D778566730Q35891582-87D81D13-6EAE-42F2-832A-85D630A27123Q36036234-EDDDD5FD-1DBD-4988-A429-ABB3B9BFB5E4Q36163201-485BB0F2-1025-4C1C-A112-3531FEB0DD08Q36246910-8D829EB2-FED5-4066-AE89-37DF06C25B82Q36299372-06B4DD53-BC30-437E-95B0-426D0F328E95Q36382758-26FB6183-344A-42CD-83CE-9E0A7B0D288CQ36603499-0CE0717A-A93D-4F49-8A9D-9F92609B2D27Q36736715-7C4BD43D-912E-403D-AD7C-12055616B08EQ36788606-DFE143BF-DF77-4140-9173-528AEC2EAC29Q37081740-3E9D90D1-B6FC-4946-96AD-FFECC0996BB4Q37179317-5116605E-7CCB-446B-84D2-535D0664EFCDQ37435171-3FC261EA-45E1-45F4-AA03-8597D172530AQ37954995-D67A35B9-B0CF-47CA-A03C-31824A3FDABDQ38144256-21F0FB5A-2ECA-4274-AD0A-43F01EBF13C2Q38193997-093BFC02-689D-4877-9096-92A877D498B4Q39215581-3D861933-4B08-40C7-B95D-B1CFC5ABB162Q39230061-7C206192-D7E2-4C72-8BAD-B5673ACDE171Q39277476-46DE59D7-5AC5-4118-B78F-076E29F6D4BAQ39414649-582CF393-9E92-455D-BF5A-F4E51BCD45B9Q39446602-0E1D6350-2076-4610-97AE-EA4F5A6B743DQ40074214-B63C428A-942D-42CA-8626-5D9F69CDF163Q48486600-752CA1B1-517B-46E1-BC66-FE8E7EDCDC8FQ53454132-1C49B25A-2880-4863-AF74-E27F0D010E36Q54377682-9F0564BC-FC8E-4C85-A77E-09F0A68AFB11Q54411913-C6780D22-7552-405F-8D2F-1524C65E2DAEQ54630819-546F4026-8BC5-41A8-B579-7BB3F2B6E912
P2860
Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Efficiency of RNA interference ...... ypes and developmental stages.
@ast
Efficiency of RNA interference ...... ypes and developmental stages.
@en
type
label
Efficiency of RNA interference ...... ypes and developmental stages.
@ast
Efficiency of RNA interference ...... ypes and developmental stages.
@en
prefLabel
Efficiency of RNA interference ...... ypes and developmental stages.
@ast
Efficiency of RNA interference ...... ypes and developmental stages.
@en
P2093
P2860
P1476
Efficiency of RNA interference ...... ypes and developmental stages.
@en
P2093
Anjana Rao
Christine Borowski
Chryssa Kanellopoulou
Corinna Paeper
Iannis Aifantis
Philipp Oberdoerffer
P2860
P304
P356
10.1128/MCB.25.10.3896-3905.2005
P407
P577
2005-05-01T00:00:00Z